Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,290.88, with a high estimate of 2,774.63 and a low estimate of 2,018.42. The median estimate represents a 22.38% increase from the last price of 1,872.00.
High | 48.2% | 2,774.63 |
Med | 22.4% | 2,290.88 |
Low | 7.8% | 2,018.42 |
Dividends in USD
Div growth (TTM) | 30.11% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +10.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.99% |
More ▼